IFNA1 and Cirrhosis: After adjusting for confounding factor which is gender, age, 12 weeks HBsAg and the presence of cirrhosis, it was found that baseline HBsAg level remained a predictor of IFN treatment (β=6.99, 95%CI: 3.59,10.40; p<0.05) (Tables 2, 3).